PsyAccess
Am I eligible?
Am I eligible?
Spravato®Registry-verifiedDesignated-centers model

Psychiatrisches Zentrum Herisau

Herisau, Switzerland

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeCovered by a national programme
  • Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 71 353 81 11
  • Websitehttps://spitalverbund.ch

About this provider

The Psychiatrisches Zentrum AR in Herisau (Krombach 3), part of the Spitalverbund Appenzell Ausserrhoden, runs a special consultation dedicated to treatment-resistant depression at its outpatient services (Kasernenstrasse 6). After a structured evaluation of psychiatric history, symptoms, prior therapy strategies and comorbidities, the team issues treatment recommendations that explicitly include electroconvulsive therapy (ECT), ketamine therapy and light therapy. The centre also offers inpatient wards for general psychiatry, psychotherapy, addiction and gerontopsychiatric acute care, a day clinic, and a telephone counselling line for relatives.

Services & programs

  • Special consultation for treatment-resistant depression: second opinions and structured diagnostic evaluation (Ambulante Psychiatrische Dienste, Kasernenstrasse 6, +41 71 353 81 99)
  • Treatment recommendations including electroconvulsive therapy (ECT), ketamine therapy and light therapy
  • Separate ECT special consultation
  • Inpatient wards: general psychiatry, psychotherapy, addiction treatment, gerontopsychiatric acute care, subacute and private wards
  • Day clinic for general psychiatry
  • Special consultation for depression in young adults
  • Telephone counselling for relatives (+41 71 353 81 80, weekdays 8.00-17.00)

Common questions

Who is the treatment-resistant depression consultation for?

It is aimed at patients, and at physicians seeking a second opinion, when depression has not responded to previous treatment. The centre states its goals as recognising treatment resistance early, treating it in time and preventing additional psychosocial consequences. Contact the outpatient services on +41 71 353 81 99 or apd@svar.ch.

Is ketamine-based treatment part of the offer?

Yes - the centre lists ketamine therapy, alongside ECT and light therapy, among the biological treatment options its recommendations may include. For OKP-reimbursed Spravato specifically, the Swiss Limitatio applies: age 18-74, at least two failed adequate antidepressants plus one augmentation attempt, CGI-S of 5 or higher, prior insurer approval (Kostengutsprache), maximum 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

25 more verified providers within 50 km

See them on the provider map →

Verification

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to Psychiatrisches Zentrum Herisau, with your consent.

What to prepare before you enquire

  • A referral or the contact details of your treating clinician
  • A list of medications you have tried (names, doses, duration)
  • A short diagnosis summary or discharge letters

Esketamine programmes usually require a documented history of antidepressant treatment.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire